Agenda


Featured Scientific Topics of 2020:
» Oncogenic Drivers Informing Personalized, Targeted Treatments in NSCLC
» Transformation of the Therapeutic Landscape in Advanced NSCLC by Immunotherapy
» Practical Considerations of Using Checkpoint Inhibitors for NSCLC 
» Interdisciplinary Efforts with Medical Oncology, Radiation Oncologists, Pathologists, and Diagnosticians
» SCLC: Finally Making Headway